Concept information
Preferred term
ChAdOx1 nCoV-19
Type
-
Topical Descriptor
Broader concept
Entry terms
- AstraZeneca, COVID-19 Vaccine
- ChAdOx1 COVID 19 Vaccine
- ChAdOx1 COVID-19 Vaccine
- COVID 19 Vaccine AstraZeneca
- COVID-19 Vaccine AstraZeneca
- COVID-19 Vaccine, ChAdOx1
- COVID-19 Vaccine, Oxford-AstraZeneca
- COVID Vaccine, Oxford-AstraZeneca
- Oxford AstraZeneca COVID 19 Vaccine
- Oxford-AstraZeneca COVID-19 Vaccine
- Oxford AstraZeneca COVID Vaccine
- Oxford-AstraZeneca COVID Vaccine
- Vaccine, ChAdOx1 COVID-19
- Vaccine, Oxford-AstraZeneca COVID
- Vaccine, Oxford-AstraZeneca COVID-19
Scope note
- A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
History note
- 2022(2021)
In other languages
-
Finnish
-
ChAdOx1 nCoV-19 -adenovirusvektorirokote
-
ChAdOx1 nCoV-19 -virusvektorirokote
-
Covishield
-
Oxford-AstraZenecan ChAdOx1 nCoV-19 -rokote
-
Oxford-AstraZenecan Vaxzevria
-
Oxford-AstraZenecan Vaxzevria-koronarokote
-
Vaxzevria
URI
http://www.yso.fi/onto/mesh/D000090985
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}